← Leaderboards
Philip Felgner
University Of California-Irvine
$10,234,165
Attributed
$10,234,165
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$10,234,165 · 1
By mechanism
N01$10,234,165 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Anshu Agrawal$3,499,313
- Joshua Robert Mauney$4,935,209
- Lbachir Benmohamed$21,933,314
- Dritan Agalliu$7,943,012
- Lisa Wagar$8,780,203
Others in their field
Other Rising Stars on “Immunologics”
- Mari Ostendorf · University Of Washington$51,931,230
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Michael Hogarth · University Of California, San Diego$14,390,863
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Atul Butte$12,440,731
Research focus
ImmunologicsAdjuvantTissuesChlamydia MuridarumClinically RelevantSideCoxiella BurnetiiProgramsInfluenzaFingerprintImmuneVaccinesAntigensOrganoidsData AnalysesAdaptive Immune ResponseTonsilData ManagementInnate Immune ResponseVaccine DevelopmentCommunicable DiseasesVaccine Antigen
Grant awards (9)
ADJUVANT COMPARISON AND CHARACTERIZATION$1,871,321
N01 · FY2025 · AI · contact PI
ADJUVANT COMPARISON AND CHARACTERIZATION$1,025,064
N01 · FY2024 · AI · contact PI
Adjuvant Comparison and Characterization$800,000
N01 · FY2024 · AI · contact PI
Adjuvant Comparison and Characterization in Influenza , Chlamydia muridarum, and Coxiella burnetii Vaccines$550,000
N01 · FY2024 · AI · contact PI
ADJUVANT COMPARISON AND CHARACTERIZATION$1,906,004
N01 · FY2023 · AI · contact PI
Adjuvant Comparison and Characterization in Influenza , Chlamydia muridarum, and Coxiella burnetii Vaccines$800,000
N01 · FY2023 · AI · contact PI
ADJUVANT COMPARISON AND CHARACTERIZATION - Influenza$550,000
N01 · FY2023 · AI · contact PI
Adjuvant Comparison and Characterization in Influenza , Chlamydia muridarum, and Coxiella burnetii Vaccines$1,381,776
N01 · FY2022 · AI · contact PI
ADJUVANT COMPARISON AND CHARACTERIZATION$1,350,000
N01 · FY2022 · AI · contact PI